Journal of AIDS & Clinical Research

ISSN: 2155-6113

Open Access


Ambale C*, Chamwona S and Kataka J

Atazanavir is a protease inhibitor that is used as an antiretroviral drug. It is co-formulated with ritonavir to boost its plasma concentration and given together with two other antiretrovirals for a highly active regimen. As much as the drug literature warns of a cutaneous reaction, it has not communicated effectively on the possibility pf this occurring in patients with a sulphur allergy. No such case has been reported before. We report a case of a cutaneous adverse drug reaction in a male patient with a known allergy to sulphur in whom it was used for post-exposure prophylaxis. There is need for taking comprehensive patient history and relate it to reactions reported in literature to prevent recurrence of adverse reactions.


Share this article

Google Scholar citation report
Citations: 5061

Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report

Journal of AIDS & Clinical Research peer review process verified at publons

Indexed In

arrow_upward arrow_upward